Bayer’s $175 million pneumonia drug fails at phase 3
November 27, 2017Research and Development, Sales and Marketing Amikacin, Amikacin Inhale, Bayer, Nektar Therapeutics, pharma
Bayer has been hit by the news that its latest effort in the pneumonia space failed at the Phase 3 …
AstraZeneca continues pivot to east with Chinese collaboration
November 27, 2017Medical Communications, Sales and Marketing AstraZeneca, biotech, drugs, pharma, pharmaceutical
It’s been a rocky year for AstraZeneca, it has scored some major successes yet its year has been marred by …
Proposed cuts to National Institutes of Health could delay up to 90% of US drug approvals
November 27, 2017Research and Development, Sales and Marketing Donald Trump, FDA, NIH, National Institutes of Health, Trump, pharma
President Donald Trump’s budget proposes to cut funding to the National Institutes of Health by $7.2 billion or 21%. Researchers …
UK government unveils pharma research HQ coup
November 27, 2017Medical Communications, Sales and Marketing MSD, biotech, drugs, life sciences, pharma, pharmaceutical
The UK government’s Autumn Budget struck a gloomy note for the economy, with figures pointing towards low productivity and the …
Top Ten most popular articles on Pharmafile.com this week
November 24, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten
As Friday comes round again, this week saw some of the biggest news of the year: Amsterdam is the new …
Different gene mutations in multiple myeloma depending on ancestry
November 24, 2017Medical Communications, Research and Development biotech, drugs, multiple myeloma, pharma, pharmaceutical
Researchers, based in the US, have conducted a large-scale collection of publicly available data and found that significant differences can …
Ex-Pharmacy Compliance Director pleads guilty to introducing illegal drugs into the market
November 24, 2017Medical Communications Department of Justice, FDA, pharma
Caprice Bearden, a 63-year old ex-Director of Compliance for an Indiana-based Pharmakon, has been found guilty of introducing adulterated drugs …
AZ partners with Combinations Alliance to test drug in cancer
November 24, 2017Medical Communications, Research and Development AstraZeneca, biotech, drugs, pharma, pharmaceutical
A clinical trial is to be launched to test AstraZeneca’s experimental drug, AZD1775, for the treatment of head and neck …
Avatar therapy holds potential as adjunct therapy for schizophrenia
November 24, 2017Medical Communications biotech, drugs, pharma, pharmaceutical, schizophrenia
Experts have developed a new form of therapy for patients living with schizophrenia, by allowing those individuals to speak to …
Drinking three cups of coffee found to hold health benefits
November 23, 2017Medical Communications biotech, coffee, drugs, pharma, pharmaceutical
In good news for coffee drinkers, drinking three to four cups of coffee was found to lower the risk of …
Learning lessons from HIV to change the treatment access landscape
November 23, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, HIV, pharma
Greg Alton, Executive Vice President of Corporate and Medical Affairs at Gilead, reveals how the rapid development and distribution of …
Tesaro secures EU approval in specific ovarian cancer population
November 23, 2017Sales and Marketing Europe, European Commission, Tesaro, Zejula, pharma
The European Commission has granted Tesaro’s Zejula (niraparib) marketing approval in Europe, it has emerged. Zejula is a poly (ADP-ribose) …
Online GP appointments found to be largely ineffective
November 23, 2017Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
There is a general push in the UK to find new digital means of reducing the workload on doctors and …
Teva looks set to axe thousands of positions and a big name
November 23, 2017Manufacturing and Production Teva, biotech, drugs, pharma, pharmaceutical
Teva’s troubled year needs little detailing, those following the company have seen it lurch from one piece of bad news …
Autumn Budget provides NHS with much-needed winter cash boost
November 22, 2017Medical Communications Autumn Budget, biotech, drugs, pharma, pharmaceutical
The Autumn Budget was announced and one of the few major announcements that had not been leaked prior to the …
Collaboration in Biopharma
November 22, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Dear Colleague, Biopharmaceutical companies are increasingly partnering with a diverse set of health care stakeholders to address scientific and technological …
Budget cuts to the President’s Malaria Initiative could risk 67 million lives, report finds
November 22, 2017Medical Communications, Research and Development Africa, Trump, USA, WHO, malaria, pharma
A team of researchers at Imperial College London (ICL) has argued that the proposal by US Congress to cut the …
‘Brain training’ found to reduce risk of dementia by 29%
November 22, 2017Research and Development biotech, dementia, drugs, pharma, pharmaceutical
In a 10-year study conducted at the Indiana University School of Medicine, researchers were able to observe a 29% reduced …
FDA approves first-ever two-drug HIV regimen, GSK’s Juluca
November 22, 2017Research and Development, Sales and Marketing AIDS, FDA, GSK, Gilead, GlaxoSmithKilne, HIV, Juluca, ViiV Healthcare, pharma
GlaxoSmithKline has announced that the FDA has awarded US marketing authorisation to the first two-drug regimen in the treatment of …
EU approves opioid treatment, amid fears of US-like crisis
November 22, 2017Research and Development, Sales and Marketing Zubsolv, biotech, drugs, opioid, orexo, pharma, pharmaceutical
The EMA has given approval for the treatment of Orexo’s Zubsolv, a therapy for the treatment of opioid dependence. The …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
